Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder.
CNS Neurosci Ther., Feb;18(2):133-41 (2012)
Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
Depress Anxiety., Feb;28(2):137-44 (2011)
A critical review of pharmacotherapy for major depressive disorder.
Int. J. Neuropsychopharmacol., Nov;14(10):1417-31 (2011)
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
J Clin Psychiatry., Feb;71(2):194-200 (2010)
Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V.
CNS Neurosci Ther., Aug;16(4):208-16 (2010)
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
J Clin Psychiatry., Mar;71(3):296-303 (2010)
An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report.
Bipolar Disord., Dec;10(8):928-42 (2008)
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.
J Clin Psychiatry., Dec;70(12):1636-44 (2009)
Cigarette smoking is associated with suicidality in bipolar disorder.
Bipolar Disord., Nov;11(7):766-71 (2009)
Stability of symptoms across major depressive episodes in bipolar disorder.
Bipolar Disord., Dec;11(8):867-75 (2009)
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
Clin Trials., Dec;6(6):637-48 (2009)
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Psychol Med., Jan;40(1):41-50 (2010)
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Bipolar Disord., Jun;11(4):391-400 (2009)
The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
Nord J Psychiatry., 63(5):420-5 (2009)
Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
Biol. Psychiatry., Sep;64(6):455-60 (2008)
Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.
Acta Psychiatr Scand., Jul;118(1):49-56 (2008)
Lessons from STEP-BD for the treatment of bipolar depression.
Depress Anxiety., 26(2):106-9 (2009)
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development.
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.
CNS Spectr., Jun;17(2):76-86 (2012)
Response rates to fluoxetine in subjects who initially show no improvement.
J Clin Psychiatry., Jul;72(7):949-54 (2011)